The Team of the Centre Virchow-Villermé
The core team of the CVV consists of two directors in Paris and two directors in Berlin as well as administrative support.
The team members are employed by their respective institutions and assume further tasks there.
An International Advisory Board has accompanied the CVV from 2013 to 2017.
You are here:
The present team of the Centre Virchow-Villermé in Berlin and in Paris
Team Berlin
- Prof. Dr. Dr. Tobias Kurth, Director Institute of Public Health, Charité - Universitätsmedizin Berlin
- Prof. Dr. Elke Schäffner, Deputy Director Institute of Public Health, Charité - Universitätsmedizin Berlin
- Susanne Stöckemann, Institute of Public Health, Charité - Universitätsmedizin Berlin
Team Paris
- Dr. Anneliese Depoux, Université de Paris
- Dr. Raphaël Porcher, Université Paris Descartes
- Marjorie Milak, Université Paris Descartes
International Advisory Board
During the first years, the Centre Virchow-Villermé was accompanied by an International Advisory Board. The members (affiliation as of 2013) were:
- François Houllier, Co-chair Paris, President Sorbonne Paris Cité
- Detlev Ganten Co-chair BERLIN, World Health Summit
- Jean-François Bach, Académie des Sciences, Permanent Secretary
- Paul Chew, Chief Medical Officer and Head of Global Medical Affairs, Sanofi
- Pierre Corvol, Collège de France
- Axel Pries, Dean Charité (ex officio)
- Jörg Hacker, President Leopoldina (ex officio)
- Ilona Kickbusch, The Graduate Institute of International and Development Studies, Geneva
- John Kimberly, Wharton Business School, University of Pennsylvania
- Claude Kirchner, Research General Delegate, Inria, Paris
- Michael J. Klag, Dean Johns Hopkins Bloomberg School of Public Health
- Patricia Oster-Stierle, Vice-President of l’Université Franco-Allemande, Sarrebruck
- Fred Paccaud, Institute for social and preventive medicine, University Hospital Center, Lausanne and Romand School of Public Health
- Peter Piot, Director London School of Hygiene and Tropical Medicine
- André Syrota, President Inserm
- Antoine Flahault, Head of the Institute of Global Health, University of Geneva